1 for each dose vs placebo group comparison in
post hoc analysis).
2 roup (P = .002 for treatment difference in a
post hoc analysis).
3 roblems of publication bias and questionable
post hoc analyses.
4 alyzed via analysis of variance and Fisher's
post hoc analyses.
5 000 SQ-T, Merck/ALK-Abello) were pooled for
post hoc analyses.
6 s intermediate between the two groups in the
post hoc analysis.
7 t tests and analysis of variance with Tukey
post hoc analysis.
8 lected dermatological data were subjected to
post hoc analysis.
9 n preventing moderate to severe relapse in a
post hoc analysis.
10 h specificity (87%) and sensitivity (78%) in
post hoc analysis.
11 o- or hyper-methylated locus without further
post-hoc analysis.
12 ACITY 006, and ASCEND) were included in this
post-hoc analysis.
13 In a
post hoc analysis,
192/885 (22%) children developed dela
14 In
post-hoc analyses,
5-year progression-free survival was
15 In a
post hoc analysis,
a cut-off value of CFT for systemic t
16 In addition, from
post hoc analysis,
a greater proportion of brolucizumab-
17 In a
post hoc analysis,
a rapid and transient increase in vir
18 We did a
post-hoc analysis after complete ICS withdrawal (months
19 Post hoc analyses also revealed a main effect of MAOA ge
20 In
post hoc analyses among female never smokers, both PM2.5
21 In a
post hoc analysis,
an approximately 4-fold difference wa
22 Although this study was a
post hoc analysis and statistically nonsignificant, this
23 ical vs surrogate primary end points, use of
post hoc analyses,
and reporting of age and sex.
24 Post hoc analysis assessed baseline demographics, diseas
25 The present
post hoc analysis assessed the end point of all-cause mo
26 In
post hoc analyses based on adherence to AT, all-cause mo
27 Post hoc analysis,
between-study differences in patient
28 Post hoc analysis by age group showed improved survival
29 nd confidence intervals can be extracted and
post hoc analysis can be carried out while maintaining s
30 In this
post-hoc analysis,
Cap-assisted colonoscopy is a safe te
31 In
post hoc analysis,
clinic visits significantly increased
32 In a
post hoc analysis,
combination therapy resulted in a hig
33 Univariate and multivariate
post hoc analyses compared effects of treatment and pati
34 In 9
post hoc analyses comparing patients initially prescribe
35 The
post hoc analysis confirmed these results and also showe
36 This
post hoc analysis demonstrated greater potassium and cre
37 Post hoc analysis did not detect any significant differe
38 Post hoc analyses established that PdE concentration inc
39 This
post hoc analysis evaluated 3 patient groups from ATTAIN
40 This
post hoc analysis evaluated the influence of select base
41 The
post hoc analyses examined the relationship of neural ab
42 This
post hoc analysis examined potential interaction between
43 This
post hoc analysis examined whether the effects of the SB
44 A
post hoc analysis exploring the effect of atrophy in the
45 by using a one-way analysis of variance with
post hoc analysis for statistically significant differen
46 A
post hoc analysis for the primary end point considering
47 e interval: 1.02-5.24; P = .045), based on a
post-hoc analysis for the modified definition.
48 Importance:
Post hoc analyses from the Diabetic Retinopathy Clinical
49 We performed
post hoc analyses from the WOSCOPS (West of Scotland Cor
50 In a
post hoc analysis from 10 ODYSSEY trials, greater percen
51 Post hoc analysis from a phase III randomized controlled
52 A
post hoc analysis from the Best Add-On Giving Effective
53 This is
post hoc analysis from the Clopidogrel for High Atheroth
54 d vaccine in young women, were combined in a
post-hoc analysis (
GlaxoSmithKline [GSK] e-track number
55 In
post hoc analyses,
greatest benefit from ART-123 was see
56 r systolic dysfunction were examined in this
post hoc analysis; &
gt;96% were taking BB at enrollment.
57 In a
post hoc analysis,
higher rates of HIV-1 protection were
58 hospital admission for heart failure in the
post hoc analysis (
HR 1.00, 95% CI 0.82-1.21) and result
59 multiple "peeks" at the data, and unplanned,
post hoc analyses (
i.e., "data dredging," "fishing exped
60 Post hoc analyses identified a similar pattern of result
61 Post hoc analysis identified a trend toward a greater in
62 In
post hoc analyses in nondiabetic individuals, a 1% incre
63 Post hoc analyses in patients who tolerated GDMT were al
64 Here, in a
post hoc analysis in 1147 patients with type 2 diabetes
65 usion in HGPIN for PCa was interrogated as a
post hoc analysis in the context of a randomized clinica
66 To this end, we performed a
post hoc analysis in the Reduction of Endpoints in NIDDM
67 We also performed a
post hoc analysis in which the rates of major complicati
68 Observational data and results from
post-hoc analyses in clinical trials suggest that direct
69 We performed a
post-hoc analysis in 2,193 men and women with SIHD from
70 er); the effect of crossover was assessed in
post-hoc analyses,
in which responses achieved after cro
71 Post hoc analyses included change from baseline sodium l
72 Post hoc analyses included voxel-based morphometry and d
73 This
post-hoc analysis included 1,030 participants in the Ger
74 When RT-ungated CMR is combined with
post hoc analysis incorporating compensation for respira
75 These
post hoc analyses indicate that patients with severe eos
76 Post hoc analyses indicated interactions between the int
77 Post-hoc analyses indicated that effects were not signif
78 A
post hoc analysis (
LOCF/BOCF hybrid) demonstrated a sign
79 However, in a
post hoc analysis,
losartan was associated with improved
80 design and data reporting, as well as use of
post hoc analyses,
may have inflated the apparent benefi
81 In a
post-hoc analysis,
mean reductions in LDL cholesterol in
82 ed; poor mental health) were examined in the
post-hoc analysis (
n = 74, 34 CBT and 40 controls), CBT
83 view is meant to allow readers to appreciate
post hoc analysis not as an entity with a single approac
84 Post hoc analyses of associations to psychosis symptoms
85 In all these cases, analyses and
post hoc analyses of data become relevant in informing p
86 Post hoc analyses of HYVET suggested that active hyperte
87 d survival in this subgroup was supported by
post hoc analyses of OS that categorized patients by the
88 Recent
post hoc analyses of several clinical trials with P2Y12
89 A mixed model repeated measures was used for
post hoc analyses of the area under the curve and peak C
90 In addition,
post hoc analyses of the datasets and challenge results
91 Six
post hoc analyses of the previously published Hypertensi
92 Post hoc analyses of the structural tractography pattern
93 Post hoc analysis of (68)Ga-PSMA-11 PET/CT implied a maj
94 evidence from 1 RCT of 21 162 patients and a
post hoc analysis of 1 RCT of 15 603 patients to answer:
95 This was a
post hoc analysis of 130 prospectively included patients
96 Post hoc analysis of 2 prospectively followed up pediatr
97 We undertook a
post hoc analysis of 2 randomized clinical trials evalua
98 Post hoc analysis of 2 similarly designed phase 3 trials
99 This
post hoc analysis of a clinical trial assessed the medic
100 This investigation was a
post hoc analysis of a cohort in the e-ROP Study (a mult
101 We performed a
post hoc analysis of a double-blind trial comparing fond
102 In this
post hoc analysis of a large placebo-controlled randomiz
103 We performed a
post hoc analysis of a phase III placebo-controlled stud
104 tion on the outcome of 30-day mortality in a
post hoc analysis of a prospective cohort study of patie
105 We performed a
post hoc analysis of a published prospective multicenter
106 In this
post hoc analysis of a randomized clinical trial which t
107 We performed a
post hoc analysis of a randomized controlled trial of no
108 ed for treatment of endovascular stroke in a
post hoc analysis of a recent randomized controlled tria
109 , and Participants: This investigation was a
post hoc analysis of a subgroup of laser control eyes in
110 This investigation was a
post hoc analysis of a subgroup of laser control eyes in
111 This was a
post hoc analysis of an intention-to-treat population of
112 A meta-analysis and a
post hoc analysis of an RCT in patients with stable card
113 In a
post hoc analysis of atopic eosinophilic subjects with u
114 In a
post hoc analysis of children weighing 65 kg or less, th
115 Post hoc analysis of clinical and laboratory features co
116 A
post hoc analysis of clinical trials of adults with acti
117 l Coherence Tomography, seems to emerge from
post hoc analysis of collected data demonstrating strong
118 This study is a
post hoc analysis of data collected during previously pu
119 om and medication score (TCS) was based on a
post hoc analysis of data collected over six trials and
120 We performed a
post hoc analysis of data from a phase 2 trial to assess
121 In a
post hoc analysis of data from a phase III study of the
122 ional review board approval was obtained for
post hoc analysis of data from a prospective single-cent
123 We conducted a
post hoc analysis of data from pilot D-Health, which is
124 Post hoc analysis of data from the 36-month prospective,
125 Post hoc analysis of data from the inception cohort asse
126 In this
post hoc analysis of data from the Physical Activity and
127 A
post hoc analysis of data from two studies was performed
128 Post hoc analysis of efficacy, safety, and resource util
129 Post hoc analysis of gene array data demonstrated signif
130 We conducted a
post hoc analysis of HF-related MACE (HF hospitalization
131 A
post hoc analysis of loci significantly associated with
132 A
post hoc analysis of Medicare Part D data revealed low p
133 An exploratory
post hoc analysis of participants with a consistent rate
134 This is a
post hoc analysis of patients enrolled in the Rituximab
135 In a
post hoc analysis of patients with an initially abnormal
136 In a
post hoc analysis of patients with moderate negative sym
137 We performed a
post hoc analysis of patients with PA bloodstream infect
138 We therefore performed a
post hoc analysis of pooled data from six randomized, do
139 Post hoc analysis of prospectively collected data.
140 A
post hoc analysis of relapse, defined as a Crohn's Disea
141 In this
post hoc analysis of ROSE AHF, the response to vasoactiv
142 In a
post hoc analysis of subjects with an estimated glomerul
143 or BITA grafts and outcomes by performing a
post hoc analysis of the ART.
144 We performed a
post hoc analysis of the Assessment of Dual Antiplatelet
145 In a
post hoc analysis of the Community-Acquired Pneumonia (C
146 In this
post hoc analysis of the DEFUSE 2 study, 35 patients wit
147 CKD progression in children, we performed a
post hoc analysis of the Effect of Strict Blood Pressure
148 We conducted a
post hoc analysis of the Folic Acid for Vascular Outcome
149 This
post hoc analysis of the Folic Acid for Vascular Outcome
150 This secondary
post hoc analysis of the MAGIC trial included participan
151 nostic factor for overall survival (OS) in a
post hoc analysis of the Mainsail trial.
152 We performed a
post hoc analysis of the METOCARD-CNIC (effect of METOpr
153 Post hoc analysis of the multicenter TTM-trial.
154 unication in advanced cancer, we conducted a
post hoc analysis of the patient intervention component,
155 This is a
post hoc analysis of the PermiT (Permissive Underfeeding
156 Moreover, a
post hoc analysis of the phase 2 trial of NP001 using th
157 A
post hoc analysis of the phase III PATRICIA (PApilloma T
158 Post hoc analysis of the phase III RIDE and RISE studies
159 mary prevention of atrial fibrillation, this
post hoc analysis of the PREDIMED trial suggests that ex
160 This is a
post hoc analysis of the PROTECT (Placebo-Controlled Ran
161 This is a
post hoc analysis of the RE-LY trial.
162 uncontrolled retrospective case series and a
post hoc analysis of the registration trial for temozolo
163 ion and subsequent outcomes in patients in a
post hoc analysis of the ROCKET AF (Efficacy and Safety
164 Cross-sectional
post hoc analysis of the Singapore Epidemiology of Eye D
165 In this
post hoc analysis of the Singapore Epidemiology of Eye D
166 Conclusion This
post hoc analysis of the single-center SIESTA trial reve
167 Post hoc analysis of the spikes evoked by the stimulatio
168 weight and follow-up visits and performed a
post hoc analysis of the Treating to New Targets trial,
169 A
post hoc analysis of the VISUAL-1 and VISUAL-2 placebo-c
170 In a
post hoc analysis of this dominant subgroup, 6-week mort
171 We here report a
post hoc analysis of this trial after a median follow-up
172 We report a
post hoc analysis of this trial after a median follow-up
173 The
post hoc analysis of time-specific measurements sheds li
174 Post-hoc analyses of an open cohort from an observationa
175 Epidemiological studies and
post-hoc analyses of clinical trials of corticosteroid t
176 We undertook
post-hoc analyses of mosquito catches made in The Gambia
177 In
post-hoc analyses of patients with nonalcoholic fatty li
178 evels of <4 or <6 million (M) IU/mL based on
post-hoc analyses of phase 3 trial data.
179 Post-hoc analysis of a prospective clinical study.
180 In a
post-hoc analysis of a prospective study, EPAGE criteria
181 Post-hoc analysis of all CYD14/15 trial participants rev
182 We undertook a
post-hoc analysis of data from the ROCKET AF (Rivaroxaba
183 A
post-hoc analysis of data from trial of patients with NA
184 We did a
post-hoc analysis of data from two replicate, randomised
185 We did a
post-hoc analysis of data, which was completed on Sept 2
186 ied subgroup analysis in August, 2013, and a
post-hoc analysis of non-inferiority and safety in March
187 In our
post-hoc analysis of pain, brief pain inventory scores i
188 Post-hoc analysis of survival to combined endpoint in SM
189 We did a
post-hoc analysis of the 3 year inhaled Steroid Treatmen
190 This was a
post-hoc analysis of the CAPRIE (Clopidogrel Versus Aspi
191 In a
post-hoc analysis of the CAPRIE population, current smok
192 In a
post-hoc analysis of the PARADIGM-HF trial, we included
193 However, in a
post-hoc analysis of the primary endpoint, the within-tr
194 However,
post-hoc analysis of the subgroup of patients not using
195 This is a retrospective
post-hoc analysis of the YELLOW II trial, comparing pati
196 Post-hoc analysis of two phase III clinical studies foun
197 In this
post hoc analysis,
patients with a GRACE score >140 were
198 In
post hoc analysis,
patients with low mycophenolic acid e
199 In this
post-hoc analysis,
patients with SIHD continued to exper
200 Design, Setting, and Participants:
Post hoc analyses performed from May 3, 2016, to June 21
201 Post hoc analyses provided weak evidence of increased mo
202 In a
post-hoc analysis,
rates of patients with inappropriate
203 In a
post-hoc analysis,
reduction of mortality was more evide
204 Post hoc analyses revealed significant activation decrea
205 Post hoc analyses revealed that antidepressants signific
206 The
post hoc analyses revealed that in the dorsal mid-insula
207 Post hoc analyses revealed that OB individuals exhibited
208 A
post hoc analysis revealed a more complex picture where
209 patients with moderate negative symptoms, a
post hoc analysis revealed significant improvement of ne
210 Post hoc analysis revealed that, relative to controls, p
211 Post-hoc analyses revealed that the glutamine/glutamate
212 dition and competency of advisor and further
post-hoc analyses revealed that this effect was more pro
213 Post-hoc analysis revealed that the effect of DRS model
214 This
post hoc analysis reveals that treatment with denosumab
215 In
post hoc analysis,
right ventricular stroke volume incre
216 roflumilast improved lung function, and in a
post hoc analysis roflumilast significantly reduced the
217 c treatment was determined at 215.5 mum in a
post hoc analysis (
sensitivity 62.5 %, specificity 96.4
218 Conclusions and Relevance: Although
post hoc analyses should be viewed with caution given th
219 h the cortical distribution of D2 receptors,
post hoc analyses showed enhanced decoding of motor sign
220 Post hoc analyses showed that the overall median time to
221 age and epilepsy [F(2,60) = 3.74, P = 0.03]:
post hoc analyses showed, for healthy children, activati
222 A
post hoc analysis showed a higher rate of relapse for pa
223 Post hoc analysis showed a low probability to reach stat
224 However, a
post hoc analysis showed that FCA increased OS in patien
225 Post hoc analysis showed that KOM had higher SBP than KO
226 A
post hoc analysis showed that this association reflected
227 Lastly,
post-hoc analysis showed a difference in the GLAST immun
228 n was 0.40 (95% CI=0.06-2.99).In contrast, a
post-hoc analysis showed that CD was associated with a s
229 Post-hoc analysis showed that the T1/2 of gastric emptyi
230 In
post hoc analyses,
significant differences in favor of a
231 In a
post hoc analysis,
stent length was the only subgroup of
232 Post hoc analyses stratified patients with FND by mental
233 In a
post hoc analysis,
subjects who received an average dose
234 RATIONALE:
Post hoc analyses suggest that blood eosinophils have po
235 Post-hoc analyses suggest that ETC-1002 may have favorab
236 Although the VHS had no overall effect,
post-hoc analyses suggest VHS might be effective in redu
237 Post hoc analyses suggested that patients not capable of
238 Post hoc analysis suggested that like the 22q11DS group,
239 noninferiority analysis was indeterminate, a
post hoc analysis suggested that VA improvement with thi
240 This
post hoc analysis suggests that adalimumab is associated
241 The VICTOR biobank was used in a series of
post hoc analyses that yielded unique and clinically val
242 In planned
post hoc analyses,
the authors examined associations bet
243 In
post hoc analyses,
the effect of treatment seemed to be
244 In a
post hoc analysis,
the 2-year cumulative incidence of he
245 In a
post hoc analysis,
the proportion of IFN-switch patients
246 In a
post hoc analysis,
the rate of major adverse cardiovascu
247 In a
post hoc analysis,
the relationship between average on-t
248 In a
post hoc analysis,
there was evidence of a reduction in
249 In a
post hoc analysis,
there was strong evidence that solar
250 We performed
post hoc analyses to evaluate the effect of humanized mo
251 We conducted a
post hoc analysis to assess the effect of coadministrati
252 A
post hoc analysis to discern sources of inter-individual
253 We conducted a
post hoc analysis to explore the potential efficacy of s
254 CE rates, thus allowing for a (prespecified)
post hoc analysis to test associations between the chang
255 In a
post-hoc analysis to compare statins, we combined data f
256 This
post hoc analysis used data from 291 patients treated wi
257 CI, 10% to 37%) by Kaplan-Meier estimate in
post hoc analysis using definitions and methods consiste
258 CI, 7% to 26%) by Kaplan-Meier estimate in a
post hoc analysis using methods consistent with historic
259 In
post hoc analysis,
video laryngoscopy was associated wit
260 In
post hoc analyses,
VM CPM and time spent in moderate/vig
261 This exploratory
post hoc analysis was conducted between October 1, 2011,
262 was conducted from 1998 to 2006; the present
post hoc analysis was conducted from March 1, 2014, to M
263 Post hoc analysis was conducted of prospectively collect
264 A
post hoc analysis was performed for delayed anemia, defi
265 A
post hoc analysis was performed of 496 patients enrolled
266 Post hoc analysis was performed of a previously conducte
267 A
post hoc analysis was performed of the Efficacy of Vasop
268 A
post hoc analysis was performed of the phase 2 trial of
269 A
post hoc analysis was performed to assess whether these
270 A
post hoc analysis was performed to determine whether uri
271 Post-hoc analysis was performed in 2,364 patients with t
272 In a
post hoc analysis we characterized clinical responders a
273 In
post hoc analyses,
we aimed to identify associations bet
274 In
post hoc analyses,
we assessed changes in invasive coron
275 With the use of a
post hoc analysis,
we addressed the association of mater
276 In a
post hoc analysis,
we also compared results to the EFS r
277 In a
post hoc analysis,
we also compared TSPO availability be
278 In this exploratory
post hoc analysis,
we analyzed patients taking an antide
279 In a
post hoc analysis,
we compared rates of proteinuria 3 mo
280 In this
post hoc analysis,
we investigated the relationship betw
281 In a
post hoc analysis,
we performed a cross-sectional observ
282 In a
post-hoc analysis,
we also investigated the effects on g
283 In this
post-hoc analysis,
we analysed complete clinical respons
284 In a
post-hoc analysis,
we analysed survival at 7 days after
285 In a
post-hoc analysis,
we found difference in blood pressure
286 In this
post-hoc analysis,
we test the hypothesis that the overa
287 In this
post-hoc analysis,
we used prospectively collected data
288 In this
post hoc analysis,
weight change at 12 and 24 months was
289 These
post hoc analyses were based on 566 women participating
290 Post hoc analyses were conducted in participants with QI
291 Subsequent
post hoc analyses were conducted to address further cuto
292 Post hoc analyses were performed after stratifying on a
293 as used to evaluate overall differences, and
post hoc analyses were performed by using the Wilcoxon s
294 Results:
Post hoc analyses were performed for 660 participants (m
295 Post hoc analyses were performed to explore the possible
296 The
post-hoc analyses were of cardiovascular death and hospi
297 ANOVA followed by Newman-Keuls
post-hoc analyses were used to test for differences betw
298 In a
post hoc analysis,
when patients with diabetes at baseli
299 We performed an exploratory,
post hoc analysis with 1255 participants (677 men and 57
300 Post-hoc analysis with Bonferroni correction revealed th